OIG September 2017 Summary: "Drug Supply Chain Security: Wholesalers Exchange Most Tracing Information"

The Office of Inspector General (OIG) issued its first in a series of examinations of drug supply chain security that will outline provisions for the implementation of the Drug Supply Chain Security Act (DSCSA). This report discusses:

-The OIG's methodology
-Key findings from the report
-Recommendations based on the FDA and OIG's findings

Want to read the entire article?

Sign-up now to instantly view the document.

Cookies